Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Innovative Pharmaceutical Biotech ( (HK:0399) ).
Innovative Pharmaceutical Biotech Limited has announced a Memorandum of Understanding (MOU) for a potential acquisition of a target company, contingent upon the target’s acquisition of Conflux Assets. The acquisition’s terms, including consideration and formal agreement, are still under negotiation, and the MOU includes a 12-month exclusivity period for discussions.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited is a company in the pharmaceutical and biotechnology industry, focusing on the development and acquisition of pharmaceutical products and technologies.
Average Trading Volume: 2,095,821
Technical Sentiment Signal: Hold
Current Market Cap: HK$378.4M
For a thorough assessment of 0399 stock, go to TipRanks’ Stock Analysis page.